National Bank of Canada
MIST icon

National Bank of Canada’s Milestone Pharmaceuticals MIST Stock Holding History

National Bank of Canada’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28K Buy
23,500
+4,800
+26% +$8.4K ﹤0.01% 2110
2025
Q4 		$37.8K Hold
18,700
– – ﹤0.01% 2016
2025
Q3 		$37.4K Hold
18,700
– – ﹤0.01% 2015
2025
Q2 		$36.1K Hold
18,700
– – ﹤0.01% 2032
2025
Q1 		$15K Hold
18,700
– – ﹤0.01% 2145
2024
Q4 		$44.1K Buy
18,700
+11,600
+163% +$19.9K ﹤0.01% 1980
2024
Q3 		$10.8K Hold
7,100
– – ﹤0.01% 2070
2024
Q2 		$9.4K Hold
7,100
– – ﹤0.01% 2138
2024
Q1 		$11.9K Buy
7,100
+3,250
+84% +$5.28K ﹤0.01% 2134
2023
Q4 		$6.85K Hold
3,850
– – ﹤0.01% 2237
2023
Q3 		$11.3K Hold
3,850
– – ﹤0.01% 2170
2023
Q2 		$11K Buy
3,850
+3,750
+3,750% +$14.1K ﹤0.01% 2155
2023
Q1 		$395 Hold
100
– – ﹤0.01% 2601
2022
Q4 		$396 Sell
100
-2,780
-97% -$14.6K ﹤0.01% 2663
2022
Q3 		$26K Sell
2,880
-11,962
-81% -$90.7K ﹤0.01% 1941
2022
Q2 		$88K Hold
14,842
– – ﹤0.01% 1600
2022
Q1 		$94K Buy
14,842
+100
+0.7% +$625 ﹤0.01% 1680
2021
Q4 		$96K Buy
+14,742
New +$88.3K ﹤0.01% 1645

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

National Bank of Canada's MIST Position: Q1 2026 in Review

National Bank of Canada increased its Milestone Pharmaceuticals (MIST) stake by 26% in Q1 2026, buying an estimated $8.4K and bringing the position to 23,500 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

National Bank of Canada first reported a position in MIST in Q4 2021 and has held it in 18 quarters since. The position peaked at $96K in Q4 2021. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • National Bank of Canada held 23,500 shares of Milestone Pharmaceuticals worth $28K as of Q1 2026.
  • National Bank of Canada bought 4,800 Milestone Pharmaceuticals shares in Q1 2026, an estimated $8.4K.
  • Milestone Pharmaceuticals made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2110 holding.
  • National Bank of Canada first reported a position in Milestone Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Milestone Pharmaceuticals position peaked at $96K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.